2,4,5,6-tetrahydrocyclopenta[c]pyrazole-3-carboxylic acid, 95.0%, 25g

2-Amino-6-methoxyphenol hydrochloride, 95.0%, 250mg

3-(piperidin-3-yl)benzoic acid hydrochloride, 95.0%, 5g

NBD-Cl (=4-Chloro-7-nitro-2,1,3-benzoxadiazole) [for HPLC Labeling]>98.0%(T)5g

{[4-(2-methylpropyl)phenyl]methyl}(propan-2-yl)amine hydrochloride, 95.0%, 1g

1-(p-Tolyl)cyclohexanecarboxylic acid, 95.0%, 25g

2-Chloro-5h,6h,7h-cyclopenta[d]pyrimidin-4-amine, 95%, 1g

[1-(6-Ethoxy-2-methylsulfanyl-pyrimidin-4-yl)-piperidin-2-yl]-methanol, 95.0%, 250mg

2-(2-phenoxyethoxy)aniline, 95.0%, 5g

5-Fluoronicotinamide, 95.0%, 5g

Ethyl 2-chloro-3-cyano-6-(trifluoromethyl)-pyridine-5-carboxylate, 95.0%, 1g

2-(Diphenylphosphino)benzonitrile>98.0%(GC)(T)200mg

5-Bromo-3-isopropyl-1-methyl-1H-indazole, 95%, 5g